2003
DOI: 10.1016/s0886-3350(03)00340-7
|View full text |Cite
|
Sign up to set email alerts
|

Visual functional outcomes of cataract surgery in the United States, Canada, Denmark, and Spain

Abstract: A previously identified variation in treatment modalities among the 4 sites did not have a significant effect on the odds of achieving an optimal functional outcome. In addition to visual acuity measurements, the VF-14 index provides information on functional outcomes that is useful, especially in studies assessing the benefits of cataract surgery in a public health care setting.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
20
3
4

Year Published

2005
2005
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(33 citation statements)
references
References 23 publications
6
20
3
4
Order By: Relevance
“…It should be noted that biometrics were made in their studies, and complicated and traumatic cataracts were excluded. But our results are below those of the Western countries [12].…”
Section: Discussioncontrasting
confidence: 91%
“…It should be noted that biometrics were made in their studies, and complicated and traumatic cataracts were excluded. But our results are below those of the Western countries [12].…”
Section: Discussioncontrasting
confidence: 91%
“…We also found that the level of visual impairment experienced by CPEO patients is significant when compared to that reported in common ophthalmic conditions such as cataract, 4 glaucoma, 5 and age-related macular degeneration (Table 3). 6 We were surprised that there were no significant differences in VF-14 scores between patients with and without diplopia.…”
Section: Eyesupporting
confidence: 50%
“…2 As ophthalmoplegia is one of the most common manifestations of mitochondrial cytopathies, any mitochondrial disease rating scale should include questions about visual function. 3 The Visual Function Index (VF-14) is a standardised vision-related quality-of-life instrument that has been validated in a wide range of ophthalmic conditions such as cataract surgery, 4 glaucoma, 5 age-related macular degeneration, 6 corneal transplantation, 7 retinal disease, 8 myopia, 9 and patients attending low-vision services. 10 Here, we report the first study to assess visual function in patients suffering from a mitochondrial disorder with ocular manifestations: CPEO.…”
Section: Introductionmentioning
confidence: 99%
“…In some, the evaluation was performed up to 4 months after surgery. 25,26 In others, like ours, it was performed approximately 3 months after surgery. 27 A strength of our study is the large sample size.…”
Section: Discussionmentioning
confidence: 83%